查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1989990

腹部縫合系統市場：按產品類型、材料、應用、最終用戶和分銷管道分類的全球市場預測，2026-2032年

Abdominal Closure System Market by Product Type, Material, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，腹部縫合系統市場價值將達到 1.9036 億美元，到 2026 年將成長至 2.0524 億美元，到 2032 年將達到 3.4654 億美元，複合年成長率為 8.93%。

主要市場統計數據
基準年 2025 1.9036億美元
預計年份：2026年 2.0524億美元
預測年份 2032 3.4654億美元
複合年成長率 (%) 8.93%

腹部閉合系統的全面概述：臨床意義、技術進步、相關人員的角色和手術安全重點。

腹部縫合系統領域處於外科技術、材料科學和醫療設備工程的關鍵交叉點，即使是微小的進步也會直接影響患者的治療結果。本文概述了臨床上對可靠且可重複的腹部縫合解決方案的需求，並重點介紹了推動產品發展的關鍵技術方向。透過將醫療設備創新與不斷變化的手術偏好以及對手術全期安全性的日益關注相結合，本文為臨床、監管和商業相關人員建立了一個策略決策框架。

生物材料的創新、醫療設備的改進、手術偏好的改變以及綜合手術模式的出現，推動了腹部縫合技術的變革性發展。

腹部縫合系統領域正經歷變革，這得益於技術進步、臨床實踐的改變以及採購模式的演變。生物材料的創新提高了黏合劑的生物相容性並最佳化了其分解特性，而器械的小型化和符合人體工學的設計則提升​​了操作便利性和手術速度。同時，臨床醫師的需求也日益趨向於能夠縮短手術時間和降低併發症風險的解決方案，促使研發人員更加重視簡化工作流程和提升系統層面的綜合價值。

分析 2025 年美國關稅措施對供應鏈、零件採購、採購方式和醫院採購的累積影響。

2025年美國關稅措施的累積影響，為整個腹部縫合生態系統的供應鏈設計、零件採購和採購實踐帶來了新的轉折點。影響進口原料、聚合物組件和成品的關稅措施凸顯了原料集中度風險，促使製造商重新評估其採購地點，並加快替代供應商的認證。實際上，這意味著對醫療設備組件關稅分類的審查力度加大，海關合規活動增多，以及對整個國際供應商網路中的到岸成本進行更積極的管理。

細分市場洞察，探索產品類型、生物材料、臨床應用、最終用戶和分銷管道如何相互交織並影響產品選擇。

細分市場分析深入觀點了臨床需求、材料科學和採購管道如何相互交織，共同影響產品的開發和應用。從產品類型來看，腹部縫合解決整體情況涵蓋了黏合劑、夾子、網片系統、縫合釘和縫線，每個類別都有其獨特的臨床和商業性考慮。黏合劑可進一步分為纖維蛋白膠和組織黏合劑，分別對應不同的生物創傷治療特性和應用技術。夾子有金屬和聚合物兩種材質，選擇時通常需要考慮滲透性、生物相容性和成本之間的平衡。網片系統分為生物來源和合成兩種。生物來源網片取自牛或豬的組織，而合成網片通常由聚酯或聚丙烯製成，每種材料在與宿主組織的整合性和抗張強度方面都表現出不同的特性。縫合釘有手動和電動兩種類型，反映了人們對手術效率和操作性的偏好。縫線則分為可吸收和不可吸收兩種選擇。可吸收縫線使用Polyglactin910和聚乙醇酸等材料，而不可吸收縫線則使用尼龍和聚丙烯等材料。這些材料的選擇取決於所需的縫合效果持續時間和組織反應。

針對美洲、歐洲、中東和非洲以及亞太地區的區域洞察，重點在於供應鏈韌性、臨床引入模式和監管差異。

區域趨勢對腹部縫合系統的臨床導入路徑、監管互動和供應鏈設計有顯著影響。在美洲，採購流程的完善和採購集團的整合為規模化生產創造了機遇，同時也帶來了壓力，需要證明其具有可靠的臨床證據和整體成本優勢。該地區公立和私立醫療機構並存的現狀凸顯了經營模式的必要性，使其能夠適應不同的合約週期和基於價值的論點。歐洲、中東和非洲（EMEA）地區的法規環境複雜，醫療資金籌措模式多樣，因此需要製定適應性強的監管策略和靈活的商業性模式，以適應各國的報銷體系和不同的臨床實踐規範。在許多EMEA市場，當地的註冊要求和公共採購流程會顯著影響產品導入時間，因此與國家意見領袖進行有針對性的溝通至關重要。

專注於競爭定位、產品系列、策略聯盟、研發重點和打入市場策略的企業洞察，從而推動企業保持領先地位。

腹部縫合領域的企業透過整合產品組合深度、材料專業知識和策略性商業性關係來脫穎而出。業界領導企業優先投資研發，以改善生物材料並開發能夠減輕臨床醫生負擔、同時維持或改善臨床療效的器械配置。與契約製造、學術機構和臨床網路建立夥伴關係和合作對於加速研發週期和獲得可靠的臨床檢驗至關重要。擁有涵蓋黏合劑、網片、縫合釘和縫合系統等多元化產品系列的企業更有能力提供整合解決方案，滿足整體外科手術的需求，並在醫院採購框架內擴大市場佔有率。

為領導者提供可操作的建議，以加速創新、加強供應鏈、簡化採購流程，並將臨床重點與商業性執行結合。

腹部縫合領域的領導者應採取一系列切實可行的操作步驟，將洞見轉化為可衡量的優勢。首先，他們應優先投資於生物材料研究，並專注於生物相容性和機械性能之間的平衡。與臨床合作夥伴共同設計試驗將提高研究的相關性並加速其應用。其次，他們應實現供應商關係多元化，並探索近岸外包和雙重採購策略，以減少對特定地區的依賴，並減輕關稅和物流中斷的影響。第三，他們應透過整合訓練、臨床結果數據和符合醫院價值導向採購要求的捆綁式服務，來增強商業性提案。

調查方法概述，涵蓋研究設計、一級和二級調查、專家訪談、檢驗以及證據整合的分析方法。

本研究設計結合了質性研究和全面的第二手資料，建構了多層次的證據基礎。主要活動包括：對循環系統、普通外科、婦科和整形外科的臨床醫生進行結構化訪談；與門診手術中心和醫院的採購和供應鏈經理進行深入討論；以及諮詢監管機構和生產專家，以了解材料採購和合規方面的考慮。二手資料研究納入了同行評審文獻、監管指導文件以及公開的生物材料和手術結果技術規範，以便更好地理解從定性研究中獲得的發現。

結論：整合關鍵的臨床、技術、監管和商業性發現，以指導腹部縫合領域的策略決策和未來優先事項。

這個結論將臨床需求、材料科學的進步、供應鏈現狀和商業策略整合為一套連貫的洞見，為未來的工作提供指導。在所有產品類型中，材料選擇和器械人體工學仍然是改善手術效果和加速臨床接受度的關鍵促進因素。關稅和貿易環境為策略規劃增添了新的維度，優先考慮加強供應鏈韌性和供應商多元化。美洲、歐洲、中東和非洲以及亞太地區的區域差異要求制定細緻的監管規劃和差異化的商業化策略，以適應當地的市場接受度因素。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 腹部縫合系統市場：依產品類型分類

  • 黏合式封口
    • 纖維蛋白膠
    • 組織黏合劑
  • 夾子
    • 金屬夾
    • 聚合物夾
  • 網格系統
    • 生物網膜
      • 源自牛
      • 源自豬
    • 複合網格
      • 聚酯纖維
      • 聚丙烯
  • 主食
    • 手動的
    • 電的
  • 縫合線
    • 吸收性
      • Polyglactin910
      • 聚乙醇酸
    • 不吸收
      • 尼龍
      • 聚丙烯

第9章 腹部縫合系統市場：依材料分類

  • 生物起源
    • 膠原蛋白
    • 豬源性細胞外基質
  • 合成
    • 聚酯纖維
    • 聚丙烯

第10章 腹部縫合系統市場：依應用分類

  • 心血管外科
  • 一般外科
  • 婦科手術
  • 整形外科

第11章 腹部縫合系統市場：依最終用戶分類

  • 門診手術中心
    • 獨立的
    • 醫院附屬機構
  • 醫院
    • 私人的
    • 民眾
  • 專科診所

第12章 腹部縫合系統市場：依分銷管道分類

  • 離線
  • 線上

第13章 腹部縫合系統市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 腹部縫合系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 腹部縫合系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國腹部縫合系統市場

第17章：中國腹部縫合系統市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • Abbott Laboratories
  • Absolutions Medical, Inc.
  • Aesculap AG
  • Applied Medical Technology, Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Canica Design Inc.
  • CONMED Corporation
  • Corza Health, Inc.
  • Essity AB
  • Ethicon, Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Smith & Nephew plc
  • Teleflex Incorporated
  • WL Gore & Associates, Inc.
Product Code: MRR-CD5A9334D821

The Abdominal Closure System Market was valued at USD 190.36 million in 2025 and is projected to grow to USD 205.24 million in 2026, with a CAGR of 8.93%, reaching USD 346.54 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 190.36 million
Estimated Year [2026] USD 205.24 million
Forecast Year [2032] USD 346.54 million
CAGR (%) 8.93%

Comprehensive introduction to abdominal closure systems outlining clinical importance, technology evolution, stakeholder roles, and priorities for surgical safety

The abdominal closure system landscape occupies a critical intersection of surgical technique, material science, and device engineering, where small advances translate directly into improved patient outcomes. This introduction frames the clinical imperative for reliable, reproducible abdominal closure solutions while outlining the major technology vectors that are driving product evolution. By situating device innovation alongside changing procedural preferences and heightened emphasis on perioperative safety, the narrative establishes the context for strategic decision-making across clinical, regulatory, and commercial stakeholders.

To maintain coherence with evolving practice patterns, the introduction emphasizes how incremental improvements in adhesives, fastening systems, mesh design, and suture technology can reduce complication rates, shorten operative time, and contribute to more predictable postoperative recovery. It also highlights the role of multidisciplinary collaboration-between surgeons, materials scientists, and supply chain professionals-in translating laboratory advances into usable products in the operating room. Finally, the section clarifies the stakeholder priorities that typically govern adoption cycles, including demonstrable safety, ease of use, compatibility with diverse surgical workflows, and clarity in reimbursement or purchasing rationale, setting the stage for deeper analytical sections that follow.

Transformative shifts in abdominal closure driven by biomaterials innovation, device refinement, procedural preference evolution, and integrated surgical models

The landscape for abdominal closure systems is shifting under a confluence of technological progress, clinical practice changes, and evolving procurement models. Biomaterials innovation is unlocking adhesives and meshes with enhanced biocompatibility and tailored degradation profiles, while device miniaturization and ergonomics are improving handling and procedural speed. Concurrently, clinician-led preferences are moving toward solutions that reduce operating room time and lower complication risk, prompting developers to place greater emphasis on simplified workflows and integrated system-level value.

In addition, cross-disciplinary collaborations are fostering hybrid solutions that blend biologic and synthetic approaches to balance host integration and mechanical strength. Regulatory pathways and post-market surveillance requirements are also adapting to novel device-material combinations, exerting greater pressure on manufacturers to demonstrate long-term safety and performance. From a commercial perspective, distribution and contracting models are evolving as providers seek more flexible sourcing options and as digital procurement channels expand access beyond traditional direct-sales relationships. Taken together, these shifts are not only altering product roadmaps but are also reshaping how clinical evidence is generated, validated, and deployed to support adoption.

Analysis of the cumulative impact of United States tariff actions in 2025 on supply chains, component sourcing, procurement approaches, and hospital procurement

The cumulative impact of United States tariff actions in 2025 has introduced new inflection points for supply chain design, component sourcing, and procurement behaviour across the abdominal closure ecosystem. Tariff measures affecting imported raw materials, polymer components, and finished devices have increased the visibility of input-concentration risk, prompting manufacturers to re-evaluate sourcing footprints and to accelerate qualification of alternate suppliers. In practice, this has meant closer scrutiny of tariff classifications for device components, increased customs compliance activity, and more active management of landed costs across international supplier networks.

Hospitals and ambulatory centers have felt the downstream effects through procurement cycles, with purchasing teams increasingly focused on total cost of ownership and on contract terms that allow pass-through of increased input costs. Providers are also more likely to request greater transparency on component origin and to favor suppliers that can demonstrate resilient logistics or local assembly capabilities. Meanwhile, innovation teams at device manufacturers are reassessing design choices where material substitution could mitigate tariff exposure without compromising clinical performance.

To navigate the tariff environment, stakeholders are implementing a range of mitigation strategies. Manufacturers are evaluating nearshoring options and diversifying supplier bases to reduce single-source dependencies. Contractual terms are being revised to share risk with buyers, and inventory management practices are being adjusted to balance working capital with supply continuity. On the regulatory side, product teams are weighing the implications of component changes on regulatory filings and post-market obligations, ensuring that any material substitutions or manufacturing transfers retain equivalence in safety and effectiveness.

Ultimately, the tariff context has reinforced the strategic importance of supply chain agility, regulatory foresight, and commercial transparency. The combined effect has been an acceleration in practical supply network redesign, a renewed focus on supplier qualification, and an increased premium on products that can demonstrate consistent availability and predictable total acquiring costs under shifting trade conditions.

Segmentation insights exploring how product categories, biomaterials, clinical applications, end users, and distribution channels converge to shape selection

Segmentation analysis offers a lens to understand how clinical needs, material science, and purchasing channels intersect to shape product development and adoption. When viewed by product type, the universe of abdominal closure solutions spans adhesive closures, clips, mesh systems, staples, and sutures, with each category bringing distinct clinical and commercial considerations. Adhesive closures divide into fibrin sealants and tissue adhesives, which cater to different wound-healing biology and application techniques. Clips are available in metal and polymer variants, where the choice often balances radiopacity, biocompatibility, and cost. Mesh systems bifurcate into biological and synthetic options; biological meshes can be sourced from bovine or porcine tissues, while synthetic meshes are typically polyester or polypropylene, each material offering a different profile for host integration and tensile properties. Staples arrive as manual and powered formats, reflecting preferences for procedural efficiency and ergonomics. Sutures present choices between absorbable and nonabsorbable materials; absorbable threads are often polyglactin 910 or polyglycolic acid, while nonabsorbable options include nylon and polypropylene, decisions that hinge on desired longevity and tissue response.

Material-based segmentation further clarifies clinical trade-offs. Biological materials such as collagen and porcine extracellular matrix are valued for their remodelling potential and compatibility with contaminated fields, whereas synthetic options like polyester and polypropylene provide predictable mechanical strength and long-term durability. Application-driven segmentation highlights divergence in requirement sets across cardiovascular, general, gynecological, and orthopedic surgery, with each area imposing unique mechanical demands and infection-risk profiles. The end-user perspective, spanning ambulatory surgical centers, hospitals, and specialty clinics, influences product selection, purchasing cadence, and service expectations; ambulatory surgical centers include freestanding and hospital-affiliated models, hospitals split between private and public ownership, and specialty clinics often seek niche solutions with focused support packages. Distribution channels-direct sales, distributors, and online platforms-shape commercial reach and pricing dynamics and determine how training, evidence dissemination, and post-sale support are delivered. By synthesizing these segmentation dimensions, stakeholders can identify where a given product aligns with clinical requirements, procurement practices, and distribution realities, thereby informing development priorities and go-to-market positioning.

Regional insights for the Americas, EMEA, and Asia-Pacific emphasizing supply chain resilience, clinical adoption patterns, and regulatory differences

Regional dynamics exert substantial influence on clinical adoption pathways, regulatory interactions, and supply chain design for abdominal closure systems. In the Americas, procurement sophistication and consolidated purchasing groups create both opportunities for scale and pressures for robust clinical evidence and favorable total cost narratives. The region's mix of private and public providers places a premium on commercial models that can accommodate varied contracting cycles and value-based discussions. Europe, Middle East & Africa presents a complex regulatory mosaic and heterogeneous healthcare financing models, demanding adaptable regulatory strategies and flexible commercial approaches that account for national reimbursement schemes and differing clinical practice norms. In many EMEA markets, local registration requirements and public procurement processes shape time-to-adoption and necessitate targeted engagement with national opinion leaders.

Asia-Pacific offers a combination of rapid clinical adoption in certain hubs and cost-sensitive procurement in others, driving manufacturers to pursue tiered product offerings and manufacturing footprints that address regional cost structures. Across Asia-Pacific, regulatory modernization in several jurisdictions has opened pathways for innovative materials, but variability in standards still requires tailored regulatory dossiers and localized clinical data. Supply chain considerations vary across regions: proximity to raw material sources, regional manufacturing capabilities, and logistics infrastructure determine lead times and inventory strategies. For international suppliers, regional regulatory heterogeneity and differing clinical preferences mean that a one-size-fits-all approach is rarely effective; instead, differentiated portfolios, flexible pricing constructs, and region-specific clinical evidence packages are required to achieve sustainable penetration. Overall, regional insights underscore the necessity of aligning regulatory planning, manufacturing strategy, and commercial execution with the unique demands of the Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company insights highlighting competitive positioning, product portfolios, strategic alliances, R&D priorities, and go-to-market strategies that drive leadership

Companies operating in the abdominal closure domain are distinguishing themselves through a blend of portfolio depth, materials expertise, and strategic commercial relationships. Industry leaders prioritize investments in R&D to refine biomaterials and to develop device configurations that reduce clinician burden while preserving or enhancing clinical outcomes. Partnerships and alliances-whether with contract manufacturers, academic centers, or clinical networks-have become central to accelerating development cycles and gaining credible clinical validation. Firms with diversified product portfolios that span adhesives, meshes, staples, and suture systems are better positioned to provide bundled solutions, address cross-surgical needs, and capture a larger share of hospital purchasing frameworks.

Competitive positioning is also shaped by go-to-market models. Companies that combine direct-sales engagement with distributor relationships and digital channels can reach a broader set of end users while tailoring commercial terms to account for the purchasing preferences of freestanding ambulatory surgical centers, hospital-affiliated ASCs, private and public hospitals, and specialty clinics. Value-added services-such as surgeon training programs, clinical data repositories, and bundled contracting options-strengthen customer relationships and create higher switching costs. Additionally, firms that cultivate robust quality systems and transparent supply-chain traceability are gaining preference among procurement teams that demand auditability and continuity of supply. Mergers and acquisitions continue to be tools for acquiring novel biomaterials expertise, expanding geographic reach, and accelerating entry into adjacent procedural areas. Taken together, these strategic choices define a competitive landscape where technical excellence, commercial adaptability, and evidence-based engagement determine market leadership.

Practical recommendations enabling leaders to accelerate innovation, strengthen supply chains, streamline procurement, and synchronize clinical priorities with commercial execution

Leaders in the abdominal closure sector should adopt a set of pragmatic, operationally focused actions to translate insight into measurable advantage. First, prioritize targeted investment in biomaterials research that balances host integration with mechanical performance; working with clinical partners to co-design trials will increase relevance and accelerate adoption. Second, diversify supplier relationships and consider nearshoring or dual-sourcing strategies to reduce dependency on single geographies and to mitigate tariff or logistics shocks. Third, strengthen commercial propositions by integrating training, clinical outcomes data, and bundled offerings that align with hospital value-based purchasing requirements.

In parallel, manufacturers and providers should modernize procurement frameworks to emphasize total cost of ownership, supply transparency, and predictable lead times. Embedding contractual mechanisms that allow for cost-sharing and clear escalation clauses will reduce friction when input prices shift. Regulatory readiness must be elevated: any material substitutions or manufacturing transfers should be preceded by rigorous equivalence testing and regulatory consultation to avert post-market complications. Finally, invest in clinician engagement by providing hands-on training, evidence summaries, and real-world performance data, and consider digital tools to capture outcomes and inform iterative product improvements. These actions, taken together, will enhance resilience, facilitate smoother adoption, and support sustainable commercial performance.

Methodology summary covering research design, primary and secondary data collection, expert interviews, validation, and analytic methods for evidence synthesis

The research design combined primary qualitative inquiry with comprehensive secondary synthesis to produce a multilayered evidence base. Primary activities included structured interviews with clinicians across cardiovascular, general, gynecological, and orthopedic specialties, in-depth discussions with procurement and supply chain leaders from ambulatory surgical centers and hospitals, and consults with regulatory and manufacturing experts to understand material sourcing and compliance considerations. Secondary research incorporated peer-reviewed literature on biomaterials and surgical outcomes, regulatory guidance documents, and publicly available technical specifications to contextualize primary insights.

Analytic techniques emphasized triangulation and validation. Interview findings were coded thematically and cross-referenced with secondary sources to identify convergent signals and to expose areas of divergence requiring further inquiry. Supply chain mapping and component provenance analysis were employed to uncover concentration risks and to evaluate potential mitigation pathways. Validation steps included iterative review sessions with external subject matter experts and cross-checks against regulatory precedents to ensure the accuracy of technical characterizations. The approach balanced qualitative depth with systematic verification to produce robust, actionable insights suitable for commercial and clinical decision-making.

Conclusion synthesizing key clinical, technological, regulatory, and commercial insights to guide strategic decisions and future priorities in abdominal closure

The concluding synthesis brings together clinical imperatives, material science developments, supply chain realities, and commercial strategy into a coherent set of insights to inform next steps. Across product categories, materials choices and device ergonomics remain primary levers for improving surgical outcomes and accelerating clinical acceptance. The tariff and trade environment has added a new dimension to strategic planning, elevating supply chain resilience and supplier diversification as priority initiatives. Regional heterogeneity-spanning the Americas, Europe, Middle East & Africa, and Asia-Pacific-requires nuanced regulatory planning and differentiated commercialization strategies to match local adoption drivers.

Companies that combine disciplined R&D investment, transparent supply chain practices, and adaptive commercial models will be best positioned to meet provider needs and to sustain long-term engagement. Providers and procurement teams, for their part, should seek partnerships that offer predictable supply, clear clinical evidence, and flexible contracting options. In sum, the evidence supports a balanced approach that simultaneously advances technical innovation, strengthens operational resilience, and aligns commercial execution with the practical demands of surgical teams and health system purchasers. This integrated perspective provides a pragmatic foundation for prioritizing initiatives that will yield durable clinical and commercial benefits.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Abdominal Closure System Market, by Product Type

  • 8.1. Adhesive Closures
    • 8.1.1. Fibrin Sealants
    • 8.1.2. Tissue Adhesive
  • 8.2. Clips
    • 8.2.1. Metal Clips
    • 8.2.2. Polymer Clips
  • 8.3. Mesh Systems
    • 8.3.1. Biological Mesh
      • 8.3.1.1. Bovine
      • 8.3.1.2. Porcine
    • 8.3.2. Synthetic Mesh
      • 8.3.2.1. Polyester
      • 8.3.2.2. Polypropylene
  • 8.4. Staples
    • 8.4.1. Manual
    • 8.4.2. Powered
  • 8.5. Sutures
    • 8.5.1. Absorbable
      • 8.5.1.1. Polyglactin 910
      • 8.5.1.2. Polyglycolic Acid
    • 8.5.2. Nonabsorbable
      • 8.5.2.1. Nylon
      • 8.5.2.2. Polypropylene

9. Abdominal Closure System Market, by Material

  • 9.1. Biological
    • 9.1.1. Collagen
    • 9.1.2. Porcine Extracellular Matrix
  • 9.2. Synthetic
    • 9.2.1. Polyester
    • 9.2.2. Polypropylene

10. Abdominal Closure System Market, by Application

  • 10.1. Cardiovascular Surgery
  • 10.2. General Surgery
  • 10.3. Gynecological Surgery
  • 10.4. Orthopedic Surgery

11. Abdominal Closure System Market, by End User

  • 11.1. Ambulatory Surgical Centers
    • 11.1.1. Freestanding
    • 11.1.2. Hospital-Affiliated
  • 11.2. Hospitals
    • 11.2.1. Private
    • 11.2.2. Public
  • 11.3. Specialty Clinics

12. Abdominal Closure System Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Abdominal Closure System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Abdominal Closure System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Abdominal Closure System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Abdominal Closure System Market

17. China Abdominal Closure System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3M Company
  • 18.6. Abbott Laboratories
  • 18.7. Absolutions Medical, Inc.
  • 18.8. Aesculap AG
  • 18.9. Applied Medical Technology, Inc.
  • 18.10. B. Braun SE
  • 18.11. Baxter International Inc.
  • 18.12. Boston Scientific Corporation
  • 18.13. Canica Design Inc.
  • 18.14. CONMED Corporation
  • 18.15. Corza Health, Inc.
  • 18.16. Essity AB
  • 18.17. Ethicon, Inc.
  • 18.18. Integra LifeSciences Corporation
  • 18.19. Johnson & Johnson Services, Inc.
  • 18.20. Karl Storz SE & Co. KG
  • 18.21. Medtronic plc
  • 18.22. Meril Life Sciences Pvt. Ltd.
  • 18.23. Smith & Nephew plc
  • 18.24. Teleflex Incorporated
  • 18.25. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ABDOMINAL CLOSURE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 274. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 275. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 278. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 279. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 299. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 300. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 303. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 304. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 305. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 306. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 307. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 308. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 309. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 310. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 311. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 312. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 313. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 314. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 315. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 316. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-203